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Immediate-type hypersensitivities are  known  to  be  mediated primarily by anti- 
bodies reacting with homologous antigens. One of the biological properties of the im- 
munoglobulins involved in immediate hypersensitivities is a capacity to sensitize skin 
such that subsequent exposure of the host to antigen results in immediate-type dermal 
reactions. 
The immunoglobulins capable of passively sensitizing skin of individuals within a 
species  (homocytotropic  antibodies,  1)  have  been  found  among  diverse  species. 
Whereas one class of homocytotropic antibody has so far been described for species 
such as rabbit (2-5), dog (6), and monkey (7), two classes have been clearly defined 
for man (8-10), rat (11-13), mouse (14-19), and guinea pig (20-30). 
To illustrate the two classes, among guinea pigs there exists a heat-stable IgG1 that 
confers passive cutaneous anaphylaxis (PCA)  1 after a  latent period of several hours 
(20-29). Though subdivision of this class has been suggested on the basis of different 
latency period requirements, i.e. 4  hr vs.  16 hr,  immunoglobulins of this type share 
common antigenic determinants (31). The second class o[ antibody, IgE or reagin, is 
heat labile at 56°C for 1 hr and induces sensitivity  persisting for many days (30, 31) 
Restricted heterogeneity has not yet been described for homocytotropic antibodies 
arising as a consequence of immunization. Nevertheless, homogeneous populations of 
imInunoglobulins have long been known to be synthesized in individuals  with myelomas 
(32-35)  and  in  those believed normal  (36).  Presumed  to arise as  a  consequence of 
monoclonal stimulation, the antibodies or their separated chains have demonstrated 
restricted antigenic specificity (32-35, 37), electrophoretic mobility (38-40), alloty~ic 
and idiotypic specificity (41,  42), and isoelectric focusing mobility (41,  43). The anti- 
gens directing production of such antibodies were either well-defined haptens (39, 44) 
or bacterial polysaccharides (34,  38, 42, 45-48). 
Dextran, one of these antigens, elicits precipitating antibodies of restricted hetero- 
geneity in humans (34, 40, 47, 48), and, indeed, has been shown to interact with mouse 
myeloma macroglobulin (49). Anti-dextran antibody synthesized at 3-4 wk by guinea 
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pigs immunized with highly purified native dextran incorporated in complete Freund's 
adjuvant was found  to be nonprecipitating,  to be homocytotropic,  and  to give PCA 
reactions best at 18 hr (50). More recently it has been shown to be synthesized in rela- 
tively tiny amounts  and to be heat stable  (Budman,  D., and J.  R. Battisto,  unpub- 
lished observations). 
The novel finding reported here is that heat-stable homocytotropic antibody 
to dextran  from individual animals  sensitizes the skin of some guinea pigs but 
not that  of others.  The nonresponse  was found to be due to nonfixation of the 
antibody in the skin.  Since the Fc portion of the irnmunoglobulin is responsible 
for fixation of the molecule in the skin  (51-53),  these observations suggest the 
existence of some type of variability in the fixing sector of Fc sites. The findings 
also indicate  that  individuals within the species  have different specificities for 
antibody  binding. 
Materials  and Methods" 
Animals.--Guinea  pigs of  six  different strains  were employed as recipients  of dermally 
deposited  homocytotropic and  heterocytotropic antibody  in these studies.  A description  of 
animals of the Abyssinian, Pirbright, Wright XIII, and Hartley strains as well as their sources 
of availability has already been given (50).  Guinea pigs of the Rockefeller University strain 
are albinos that have been pen-inbred at the Rockefeller University in New York City; those 
of the  Weiser strain  are  nonalbinos  maintained  at  the National Jewish Hospital,  Denver, 
Colo. 
Dextrans.--Three  preparations of dextran were used in the work reported here. Two have 
already  been described  (50). One is whole native  dextran  SDD  3580-10  prepared  from  a 
sucrose-grown culture of Leuconostoc mesenteroldes NRRL 512(F)  which contains less  than 
0.01%  nitrogen and  has a  molecular weight of 20-50 million. This dextran is a  1:6,  1:3  ~- 
glucoside and was used  for immunizing guinea pigs as well as for challenging guinea pigs in 
PCA tests. 
The second  dextran, a  1:6,  1:4 a-glucoside, was synthesized from dextrin by Acetobacter 
capsulatum NCTC 4943. It contains less than 0.05% nitrogenous impurity and has a molecular 
weight similar to that of 512 (F). 
The third dextran was purchased from Nutritional Biochemicals Corp., Cleveland, Ohio, 
Lot. No. 7600. It has a molecular weight  of  5-40  million and contains nitrogenous impurities 
approximating 200 ~g/mg. The last  two mentioned dextrans were used exclusively in com- 
parative PCA tests. 
Antisera.--Dextran-specific  antibodies used in these studies were derived from guinea pigs 
of the Abyssinian strain that had been immunized with dextran from Leuconostoc mesenteroides 
NRRL 512(F).  The animals were immunized as has been described (50). Briefly, each guinea 
pig was injected with dextran that had been passed through a Millipore filter (pore size 0.45/z) 
and emulsified  in Freund's complete adjuvant. Each animal received 1 or 2 mg of dextran (in 
1.5 ml saline emulsified  with an equal volume of adjuvant) divided between the nuchal region 
(2.8 ml) and each hind footpad (0.1 m|). Routinely, the animals were skin tested with 125 or 
200/zg of dextran  (in 0.1 ml saline)  at 20-30 days after initiation of immunization and bled 
1 wk thereafter. 
Rabbit serum containing antibody to pneumococcus Type 2 polysaccharide  (preparation 
kindly supplied by Lederle Laboratories, Pearl River, N. Y.) was also used in one phase of this 
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responses of guinea pigs. As a source of heterocytotropic antibody it resulted in PCA reactions 
measuring l0 X  10 mm when used in 50 ng amounts. In this quantity it was employed as a 
standard against which guinea pig anti-dextran sera were compared.  When guinea pig sera 
were diluted to extinction, those dilutions provoking PCA reactions equal in size to that given 
by the standard were assumed to contain 50 ng of antibody. 
PCA  Tests.--PCA was routinely performed  by injecting 0.1  ml of neat or,  more often, 
diluted serum into the dorsal skin of young guinea pigs (250-400 g) and after an 18 hr interval, 
administering intravenously 2 mg of dextran in 1 ml of saline pins 1 ml of 0.5% Evans blue 
dye in saline. Averaged millimeters of crossed diameters and intensities of blueing were noted 
at 30 min. 
Iodination  o.f  Anti-Dextran  Homocytotropic Antibody.--With  minor  modifications,  the 
method of McConahey and Dixon  (54)  was used to iodinate dextran-specific antibodies of 
two types after their adsorption to Sephadex (48).  Sephadex (Grade G100, Pharmacia Fine 
Chemicals, Uppsala, Sweden) was washed 50 times in 0.15 ~t sodium chloride solution and 3 
times in phosphate-buffered saline (PBS). Guinea pig sera A-5691 (type 1) and A-5708 (type 
2),  each containing approximately 5 #g  of antibody/ml, were added in 1.5  ml amounts to 
separate 1 ml portions of a packed slurry of Sephadex. The mixtures were incubated at 37°C 
for 1 hr and at 4°C for 18 hr. This procedure was known from our prior experiments to adsorb 
the homocytotropic antibody.  Thereafter the Sephadex was washed  three times in  excess 
PBS to rid the supernatant fluid of unadsorbed serum proteins. To achieve mild oxidation and 
labeling, 10 #g of chloramine-T (Eastman Organic Chemicals, Rochester, N.Y.)  and 20 #Ci 
of 125I (Na125I  in 0.1 ml NaOH, 20 mCi/ml; carrier-free, Lot  11701, New England Nuclear 
Corp., Boston, Mass.) were added successively to each tube. Coupling was allowed to proceed 
for 0.5 hr at 4°C after which the slurry was washed three times with excess PBS. The iodinated 
antibody was removed from the Sephadex by adding 2 ml of 0.2 M sodium acetate buffer at 
pH 4.0 and stirring for 0.5 hr. The supernatant was then dialyzed against large volumes of 
0.15 M NaC1 over a 3 day period at 4°C. 
Monitoring the dialysis fluid by scintillation counting at this time showed it contained 50 
cpm/ml while the solutions within the dialysis sacs possessed 35,000 cpm/ml for serum A-5691 
and 50,000 cpm/ml for serum A-5708. 
Preparation  of Skin for Scintillation  Counting.--Guinea  pigs were injected in the dorsal 
skin with 0.1 ml of the two preparations of 125I-labeled  anti-dextran antibodies (300-400 ng/ 
site). A fixation period of  18 hr was allowed to elapse when the animals were sacrificed by 
cervical dislocation. Skin directly over each injection site (2 cm  2) was excised and was sub- 
divided into five equal pieces. The pieces were finely minced and placed into separate scintil- 
lation vials, to each of which was added 2 ml of NCS Solubilizer (Amersham-Searle Corp., 
Des Plaines, Ill.). Incubation at 37°C proceeded until complete dissolution of the tissue oc- 
curred (generally several days) when 8 ml of scintillation fuid (4 g of Omnifluor [New England 
Nuclear Corp.]  per liter of toluene) was added to each vial. After  an  additional  24  hr  the 
vials were read on a Beckman Model LS230 scintillation counter. The counts per minute of 
each  of the five subdivided sections minus  background counts were added  to  achieve the 
total counts per minute per injection site. 
RESULTS 
During the course of assaying the sera of guinea pigs immunized with highly 
purified  dextran,  guinea  pigs  were  found  that  would  not  respond  with  PCA 
reactions to some sera known to contain heat-stable, homocytotropic,  dextran- 
specific  antibodies,  while  at  the  same  time  they  exhibited  PCA  reactions  to 
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were  made at  random  and  subsequent  reflection upon  their relevance to  our 
knowledge of immediate-type sensitivities prompted a  thorough investigation 
of the phenomenon. 
Three sera containing anti-dextran antibodies were first assayed for content 
of antibodies. This was accomplished by comparing their ability to elicit PCA 
reactions equal to that of a known quantity of rabbit antiserum to pneumococcal 
Type 2 polysaccharide known to cross-react with dextran.  (See Materials and 
Methods for the manner  of antibody estimation.)  Equivalent quantities  (100 
ng)  of each of the three sera were then injected into a  series of guinea pigs to 
determine the patterns of response and nonresponse  they would evoke under 
TABLE I 
Typical  Variability  of Responses to Dextran-Specific PCA  Antibodies 
Guinea pig  PCA diameters  (mm) to anti-serum* type 
Group  Number  1  2  3 
1, 2, 3  R457  19  13  25 
R458  26  15  28 
1, 3  R448  15  0  26 
R446  12  0  17 
2  5745  0  13  ND 
3  HI  0  0  18 
H2  0  0  17 
ND  =  not done. 
* Each antiserum was first diluted to its end point to determine the quantity of antibody 
present and then 100 ng/site was used. Average of crossed diameters is given. 
comparable  conditions.  After  an  18  hr  interval  the  recipient  animals  were 
intravenously injected with  2  mg  of dextran  and  Evans  blue dye to develop 
reactions. Some typical results given in Table I  reveal that certain guinea pigs 
(listed as group  1,  2,  3)  were  capable of  responding to  all three  sera.  Some 
animals were  found  to  give reactions to sera  1,  and 3  but  not  to  2.  A  single 
animal responded to serum 2 but not to 1 ; and still others reacted only to serum 
3  but not to 1 or 2. In this way the original random observations that certain 
animals supported reactions to some antibodies but not to others that had been 
produced  to  the  same  antigen  were  amply confirmed. 
Of  the  several  explanations  that  could  account  for  these  results,  the  first 
tested was that guinea pig recipients might be able to inactivate the homocyto- 
tropic immunoglobulins of certain donors. To ascertain whether  this was true, 
2-3 ml of blood was collected from virgin guinea pigs into sodium citrate before 
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responded with PCA to antiserum type 1 and others did not. The whole, citrated 
blood  of both  sorts  of animals  was  mixed in equal  proportions  with  type  1 
antiserum containing 500 ng of antibody and allowed to incubate for 20 min 
at  37°C  before  centrifugation.  The  clear  supernatants  were  used  for  PCA 
tests in  a  new  set of guinea pig recipients. 
From  the  latter  tests  it  was  found  that  whole  blood  derived  from PCA- 
negative donors was unable to neutralize  (or remove) dextran-specific type 1 
antibody  (Table II).  Comparable PCA  reactions were achieved whether  the 
antibody had been mixed with whole blood derived from animals that had or 
had not demonstrated PCA reactions to antibody type 1. From such informa- 
tion it was possible to eliminate the idea that PCA antibodies were being inac- 
tivoted in PCA-negative animals. 
TABLE II 
Inability of Whole Blood from PCA (--) Guinea Pigs to Neutralize  Homocytolropi~ Dextran- 
Specific Antibody 
Type 1 antibody* mixed with whole blood of  PeA reactions in R 203 
(ram) 
PCA(+) animal 
H 103  15 
V 431  16 
PCA(--) animal 
V 415  14 
A 5752  20 
* Final concentration of antibody injected was 100 ng/site. 
An  alternate  hypothesis involved the  possibility that  antibodies  possessed 
different specificities. The linear chains in the dextran used for immunization 
are 1: 6 a-glucosidic groups while the branching units are 1 : 3 a-glucosidic bonds. 
The possibility existed that the combining areas of the antibodies might have 
specificities directed  to these different areas of the dextran molecule. To test 
this hypothesis a dextran that lacked 1 : 3 a-glucosidic bonds was used for PCA 
tests,  so that only antibody directed  to the  1:6 configuration was measured. 
Guinea pigs were injected with  100  ng of antibody types 1 and 2 and half 
were challenged with  the same dextran used for immunization,  i.e.  that  con- 
taining 1 : 6,  1 : 3 a-glucosidic bonds, while the other half received dextran com- 
posed of 1 : 6, 1 : 4 a-glucosidic bonds. Reactions of comparable size were elicited 
by both antigens  (Table III). Thus,  the antibodies responsible for divergent 
PCA results possess essentially a single specificity, i.e., one directed to the 1:6 
a-glucosidic configuration of dextran. 
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to evoke PCA reactions could be their differential ability to fix in skin. Fixation 
is known to be a  property of the heavy chain portion of the molecule, the Fc 
fragment  (51).  Subtle  differences  in  this  segment  could  result  in  separate 
binding abilities which in turn  could account  for the variable PCA  reactions 
observed. 
The use of radioactively trace-labeled homocytotropic antibodies was thought 
best to test this supposition. Type 1 and type 2  antibodies were labeled with 
TABLE III 
Typical PCA Responses* Evoked by Two Dextrans with Similar Linear but Different Branching 
Bonds 
Antibody~:  a-glucosidic  bonds 
Type  Amount injected  1:6, 1:3  1:6, 1:4 
(ng) 
1  100  17  21 
2  100  15  19 
* Average of crossed diameters given. 
:~ Synthesized  to dextran with 1:6, 1:3 a-glucosidic structure. 
TABLE IV 
Differential Binding of t~5I-Labeled Homoeytotropic Antibodies 
cpm 
Type of Antibody 
1  2 
Injected dermally (0.1 ml) 
Recovered* from skin of guinea 
pigs: 
(X 10~)  (X 108) 
3.5  5.0 
R 493  2.9  1.7 
H 711  1.8  1.5 
* After 18 hr. 
a2~I and equal portions were injected into the skin of guinea pigs. After an 18 
hr incubation,  2  cm  2 segments  of dermis surrounding the injection  sites were 
excised, dissolved in a solubilizer, and the retained counts read in a scintillation 
counter. 
The  results,  shown  in  Table  IV,  indicate that  preferential binding of  the 
antibodies in some skin does indeed occur. Although an equal number of counts 
per minute of type 1 antibody were injected into guinea pigs R-493 and H-711, 
considerably more remained localized in the skin of animal R-493  than  were 
found in the skin of animal H-711. In addition, although comparable amounts JACK R.  BATTISTO, DANIEL BUDMAN, ROBERT FREEDMAN  387 
of antibody type 2  (possessing slightly greater specific activity) were injected 
into the same animals, neither animal demonstrated retention of this antibody 
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FIG. 1.  Schematic representation of specificity between homocytotropic antibody Fc and 
fixation sites. Only for simplicity is the variability  in Fc sites shown at the terminal portion of 
both heavy chains. 
TABLE V 
Distribution  o[ Fixation Specificities for Antibody Types 1 and 2 among Guinea Pigs of Diverse 
Strains 
Guinea  pig strain 
No. of animals  fixing 
Both 1 and 2  Only 1  Only 2  Neither  1 nor 2 
Rockefeller University  7  7  4 
Pirbright  3  3  3 
Wright XIII  4  1  1 
Weiser  1  1 
Abyssinian  2  1  1  2 
Hartley  2  5 
Totals  19  13  1  15 
Per cent of total  40  27  2  31 
firmation of the hypothesis that differential binding of these antibodies occurs 
in  skin  of  various  animals was  established. 
To visualize differential binding, Fig. 1 was prepared. Here are schematically 
shown the variability in the Fc sites of antibodies type 1 and 2 and the com- 
plementarity of loci in the skin to which the Fc fix. 
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guinea pigs,  animals of diverse strains were tested for PCA responses to ap- 
proximately equal amounts of antibodies type 1 and 2. As can be seen from the 
data of Table V, animals fixing both were present in every strain tested. Those 
with  receptors  only for type  1  have been found  so far in  all strains  except 
Hartley. Only a  single animal fixing type 2 but not 1 was detected; it was an 
Abyssinian guinea pig. All strains studied, except the Weiser strain, had animals 
incapable of fixing both types of antibodies. From the percentages given at the 
bottom of Table V  it is apparent that about a  third of all animals tested are 
incapable of supporting PCA reactions  to the two homocytotropic, dextran- 
specific antibodies. Slightly more than a  third of the animals were seen to re- 
spond to both antibodies and slightly less than a  third were found to react to 
only one of the antibodies. 
A search was made to determine the frequency of occurrence of the different 
types of dextran-specific homocytotropic antibodies. Although a large number 
TABLE  VI 
Frequency of Occurrence and Quantity  of Dextran-Spedfic  Antibodies Characterized by 
Differential Binding  in Skin Through Fc Sites 
Antibodies possessing 
Fc 1  Fc2  Fc3  Fc4  Fe5 
No. of each detected  4  1  1  1  1 
Greatest quantity (#g/ml)*  40  5  40  5  40 
* See Materials and Methods for quantitati0n. 
of sera were assayed (Table VI), the complexity of the assay allowed inclusion 
of only eight sera with certainty. Of the eight, at least half appeared similar to 
type 1 and the remainder were different from type 1 and from each other. An 
estimate of the greatest quantity of antibody detected among these sera is also 
given (Table VI). It is apparent that the quantities of antibody produced are 
consistently low; amounts greater than 40 #g/ml have not been detected. 
DISCUSSION 
The novel observation reported here is that individual guinea pig sera con- 
taining  homocytotropic, heat-stable  anti-dextran  antibodies  elicit  PCA  reac- 
tions in some individuals but not others within the homologous species. Prior 
experience with similar type antibodies to other more complex antigens,  such 
as bovine gamma globulin and dinitrophenyl bovine fibrinogen, had established 
that  they uniformly sensitize virtually  all  young  guinea  pigs  for  PCA.  The 
remarkable  dichotomy  between  these  two  sets  of  observations  may  be  ac- 
counted  for  primarily  by  the  stereochemistry  of  the  antigens  used  for  im- 
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substance with a  maximum of two antigenic specificities,  one for the linear 
1:6  glucose configuration and the other for the branched  1:3  arrangement. 
Since 96%  of the dextran molecule is composed of the former, this polysac- 
charide is probably recognized immunologically as essentially a single antigenic 
moiety. During immunization it may stimulate only a few immunocompetent 
cells, thereby giving rise to a restricted population of antibody molecules with 
a  circumscribed specificity for fixing to only certain guinea pig skin. On the 
other hand, immunization with more complex structures such as proteins could 
be  expected  to  provide  multiple  antigenic  moieties  capable  of  stimulating 
many more clones of cells to produce a heterogeneous population of antibody 
molecules. The latter would possess  a broader range of skin-fixing specificities 
capable of sensitizing the skin of virtually any guinea pig. 
The idea that the antibody arises from a  single clone of cells  stimulated 
essentially by a single antigenic moiety may also account for the rather small 
amounts of antibody that have been recoverable. Despite repeated injections 
of the antigen into some guinea pigs over prolonged intervals of time, amounts 
of antibody greater than approximately 40/~g/ml were not attained. 
Should this interpretation prove to be correct, the use in immunization of 
synthetic molecules possessing one or two antigenic moieties might be expected 
to yield homogeneous immunoglobulins with skin-fixing specificities  similar to 
those described here. 
Yount  et  al.  (47),  in  studying the  precipitating  anti-dextran  antibodies 
elicited in humans, have commented that the striking homogeneity they have 
observed in these antibodies may possibly relate to the carbohydrate nature of 
the antigen. Curiously these antibodies were found only in the ~'G2 subgroup of 
immunoglobulins and were virtually incapable of provoking PCA reactions in 
guinea pigs (55).  This particular subgroup lacks the ability to act as hetero- 
cytotropic antibodies in the guinea pig primarily because the immunoglobulins 
do not fix in the skin of this species of animal (56). 
To explain the variable sensitizability achieved with anti-dextran antibodies, 
several possibilities were envisioned and tested. The only one supported by the 
data collected thus far is that the antibodies in individual sera possess differing 
capacities to bind in skin. Thus, 125I trace-labeled type 1 antibodies remained at 
18 hr fixed in the skin of one guinea pig but not in that of another. Similarly 
labeled type 2 antibodies were not significantly retained in the skin of either of 
these animals. These results are comparable to those observed when the non- 
labeled antibodies were used for PCA. 
Other possibilities that were eliminated were (a)  that whenever type 1 or 
type 2 antibodies were unable to elicit PCA in some guinea pigs they were being 
neutralized, and (b) that the two types of antibodies possessed different antigen- 
combining specificities.  It was  actually found that  the  antibodies were  not 
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antibodies used in these experiments possessed a single specificity directed to 
the  1:6  a-glucosidic  configuration  of  dextran.  Another  possibility  was  (c) 
that the antibodies possessed different-sized antigen-combining sites.  Schloss- 
man  and  Kabat  (57)  had  shown  that  anti-dextran-precipitating  antibodies 
produced  in  humans  consisted  of  populations  of  molecules  heterogeneous 
primarily with regard to the size of the antibody-combining site. The size of the 
antigen-binding site of the antibody molecule was found to have an upper limit 
corresponding to 4,  5,  or 6 glucose residues.  Richter  (58)  has confirmed this 
finding  in  PCA-inhibition  studies  using  antibody  derived from  guinea  pigs 
immunized with Leuconostoc mesenteroides B512 cell debris. In the work reported 
here,  the size of the antibody-combining sites  of the PCA  antibody was not 
studied  primarily  because  the  antibodies  were  always  detected  by  dextran 
preparations that excluded dextran fragments with molecular weights smaller 
than 5 million. As the PCA differences were observed under these conditions, 
size of the antibody-combining site was considered an unlikely explanation. 
The portion of an immunoglobulin molecule that  results in its fixation in 
the skin is the Fc fragment (51-53, 56). Although Fc is widely regarded to be 
the invariant end of the heavy chain,  the results reported here suggest that 
some subtle variability must exist to account for the different fixations observed. 
These small  structural  differences may be  allotypic variations  analogous  to 
Gm  allotypes on  the  Fc fragment of human  immunoglobulins  (see 59,  60). 
Indeed,  fixation of immunoglobulins  to  tissue may be  one of the  functions 
served by allotypy. In the work reported here, antibodies with five different Fc 
sites have been distinguished,  but one was encountered more frequently than 
the others. Thus far the exact area and composition of the Fc segment responsi- 
ble for fixation of the antibody molecule in skin is unknown.  However, it is 
known to be degradable by proteolysis and to be rendered incapable of fixation 
to skin after treatnlent of the antibody molecule with mercaptoethanol (52, 53). 
The data presented here also suggest that complementariness to the variable 
Fc of immunoglobulins must exist at loci where antibodies become fixed. Several 
fixation specificities must  be present  in  each  animal.  Although  at  least five 
types have been observed in guinea pigs, additional ones may exist and, indeed, 
the total is unknown. Whether there is heritable control over the fixation speci- 
ficities and whether they are related to histocompatibility antigens are questions 
presently under consideration. 
Differing  receptor  specificities  for  homocytotropic antibodies  of  the  IgE 
class may also exist. Kisil et al. (61),  studying the Prausnitz-Kiistner response 
in volunteers observed that  activity profiles obtained with  the same allergic 
sera  in  different volunteers were not  identical.  They suggested  that  reagins 
are  heterogeneous with  respect  to  skin-fixation properties.  Whether fixation 
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antibodies is unknown. Also unknown is whether an individual always possesses 
fixation  specificities  for the  Fc of his own homocytotropic antibodies.  If this 
were a random event, then an explanation would be at hand for the presence of 
sensitizing  antibodies  within  an individual  who himself  lacks  clinical  signs of 
sensitivity for an homologous allergen. 
SUMM~RY 
The  heat-stable,  homocytotropic  antibody  synthesized  by  guinea  pigs  to 
highly  purified  dextran  has  been  studied  by  passive  cutaneous  anaphylaxis 
(PCA). Antibody arising in single guinea pigs was found to give PCA in some 
homologous recipients  but  not  in  others.  Data  are  presented  which  indicate 
that the antibodies  are bound in the skin of some animals to a  greater degree 
than in that of others. This suggests some type of variability, perhaps allotypic, 
in the Fc portion of these immunoglobulins which relates to specificities of the 
loci where Fc becomes fixed in skin. 
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